Insider · CIK 0002027869
Bobby Saadati
Files at REPX (Riley Exploration Permian, Inc.), CRC (California Resources Corp). First filing -, latest -.
In brief
Bobby Saadati files SEC Form 4 as director at REPX (Riley Exploration Permian, Inc.), and also at CRC (California Resources Corp). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Bobby Saadati has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 15, 2026 | REPX Riley Exploration Permian, Inc. | AGrant or award Common Stock, par value $0.001 per share | +7,143 | $0.00 | $0 | 9,021 | May 19, 2026 |
| Mar 1, 2026 | REPX Riley Exploration Permian, Inc. | AGrant or award Common Stock, par value $0.001 per share | +1,878 | $0.00 | $0 | 1,878 | Mar 2, 2026 |
| May 2, 2025 | CRC California Resources Corp | AGrant or award Common Stock | +5,698 | $0.00 | $0 | 9,063 | May 6, 2025 |
Questions about Bobby Saadati
Answered from the filings on this page, as of the latest one.
Is Bobby Saadati buying or selling?
Bobby Saadati has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Bobby Saadati's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Bobby Saadati has 0.
Where does Bobby Saadati file Form 4?
Bobby Saadati has filed Form 4 at REPX (Riley Exploration Permian, Inc.); CRC (California Resources Corp). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.